Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents

NCT03056118 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1368

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Heart Disease

Interventions

DRUG: 6-month dual anti-platelet therapy
DRUG: 12-month dual anti-platelet therapy
DEVICE: Zotarolimus eluting stent
DEVICE: Biolimus eluting stent

Sponsor

Gangnam Severance Hospital